COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
This Guidelines summary includes recommendations on recognition and diagnosis of actinic keratosis, use of clinical findings, management and options for treatment. It includes an algorithm of the pathway from recognition to treatment in primary care, including red flags to recognise.
This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.